Expression of a disintegrin and metalloprotease in human abdominal aortic aneurysms

Journal of Vascular Research

Volumn 49, Issue 3, 2012, Pages 198-206

  Lipp, Christina ^a   Lohoefer, Fabian ^a   Reeps, Christian ^a   Rudelius, Martina ^a   Baummann, Markus ^a   Heemann, Uwe ^a   Eckstein, Hans Henning ^a   Pelisek, Jaroslav ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

A disintegrin and metalloprotease family; Abdominal aortic aneurysm; Aorta

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; PROTEIN ADAM12; PROTEIN ADAM15; PROTEIN ADAM17; PROTEIN ADAM8; PROTEIN ADAM9; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; AORTA WALL; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

ADAM PROTEINS; ADULT; AGED; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84858329983     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000332959     Document Type: Article

References (29)

1. Eckstein H, Böckler D, Flessenkämper I, Schmitz-Rixen T, Debus S, Lang W: Ultrasonographic screening for the detection of abdominal aortic aneurysms. Dtsch Ärztebl Int 2009; 106: 657-663.
2. Sakalihasan N, Limet R, Defawe OD: Abdominal aortic aneurysm. Lancet 2005; 365: 1577-1589. (Pubitemid 40615407)
3. Lederle FA: In the clinic: abdominal aortic aneurysm. Ann Intern Med 2009; 150:ITC51-ITC515.
4. Golledge J, Muller J, Daugherty A, Norman P: Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006; 26: 2605-2613.
5. Guo DC, Papke CL, He R, Milewicz DM: Pathogenesis of thoracic and abdominal aortic aneurysms. Ann NY Acad Sci 2006; 1085: 339-352. (Pubitemid 47091985)
6. Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ: Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb 1991; 11: 1667-1677.
7. Pearce WH, Shively VP: Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann NY Acad Sci 2006; 1085: 117-132. (Pubitemid 47091997)
8. Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML: An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovasc Surg 2005; 39: 457-464. (Pubitemid 41790136)
9. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-2503. (Pubitemid 24379627)
10. Blobel CP: ADAMs: key components in EGFR signalling and development. Nature 2005; 6: 32-43. (Pubitemid 40064897)
11. Seals DF, Courtneidge SA: The ADAMs family of metalloproteaes: multidomain proteins with multiple functions. Genes Dev 2003; 17: 7-30. (Pubitemid 36062504)
12. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, et al: Distinct roles for ADAM 10 and ADAM 17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164: 769-779. (Pubitemid 38282960)
13. Dreux AC, Lamb DJ, Modjtahedi H, Ferns GA: The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis 2006; 186: 38-53.
14. Van Goor H, Melenhorst WB, Turner AJ, Holgate ST: Adamalysins in biology and disease. J Pathol 2009; 219: 277-286.
15. Millichip MI, Dallas DJ, Wu E, Dale S, Mc-Kie N: The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun 1998; 245: 594-598. (Pubitemid 28418550)
16. Mochizuki S, Okada Y: ADAMs in cancer cell proliferation and progression. Cancer Sci 2007; 98: 621-628. (Pubitemid 46563436)
17. Herren B, Raines EW, Ross R: Three putative integrin ligands identified in human aortic smooth muscle cells. Ann NY Acad Sci 1997; 811: 498-505. (Pubitemid 27308358)
18. Satoh H, Nakamura M, Satoh M, Nakajima T, Izumoto H, Maesawa C, et al: Expression and localization of tumour necrosis factoralpha and its converting enzyme in human abdominal aortic aneurysm. Clin Sci (Lond) 2004; 106: 301-306. (Pubitemid 38365837)
19. Edwards DR, Handsley MM, Pennington CJ: The ADAM metalloproteinases. Mol Aspects Med 2008; 29: 258-289.
20. Murphy G: Regulation of the proteolytic disintegrin metalloproteinases, the 'Sheddases'. Semin Cell Dev Biol 2009; 20: 138-145.
21. World Medical Association Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997; 35: 2-3.
22. Choke E, Cockerill G, Wilson, Sayed S, Dawson J, Loftus I, et al: A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2005; 30: 227-244. (Pubitemid 41086292)
23. Thompson RW, Baxter BT: MMP inhibition in abdominal aortic aneurysms: rationale for a prospective randomized clinical trial. Ann NY Acad Sci 1999; 878: 159-178. (Pubitemid 29353568)
24. Oksala N, Levula M, Airla N, Pelto-Huikko M, Ortiz RM, Jaervinen O, et al: ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries-Tampere vascular study. Ann Med 2009; 41: 279-290.
25. Holdt LM, Thiery J, Breslow JL, Teupser D: Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice. Arterioscler Thromb Vasc Biol 2008; 28: 1097-1103.
26. Canault M, Leroyer AS, Peiretti F, Lesèche G, Tedgui A, Bonardo B, et al: Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am J Pathol 2007; 171: 1713-1723. (Pubitemid 350158331)
27. Al-Fakhri N, Wilhelm J, Hahn M, Heidt M, Hehrlein FW, Endisch AM, et al: Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis. J Cell Biochem 2003; 89: 808-823. (Pubitemid 36759140)
28. Langer H, May AE, Bültmann A, Gawaz M: ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation. Thromb Haemost 2005; 94: 555-561. (Pubitemid 41300852)
29. Brocker CN, Vasiliou V, Nebert DW: Evolutionary divergence and functions of the ADAM and ADAMTS gene families. Hum Genomics 2009; 4: 43-55.